Outcomes and risk analysis after tricuspid valve surgery for non-Ebstein 2-ventricle congenital tricuspid valve diseases

Blitzer, D., Bouhout, I., Al Haddad, E., Lewis, M., Farooqi, K., Shah, A., Zemer-Wassercug, N., Singh, H., Anderson, B., Bacha, E., & Kalfa, D. (2022). Outcomes and risk analysis after tricuspid valve surgery for non-Ebstein 2-ventricle congenital tricuspid valve diseases. JTCVS Open, 11, 351–362. https://doi.org/10.1016/j.xjon.2022.06.017
Authors:
David Blitzer
Ismail Bouhout
Eliana Al Haddad
Matthew Lewis
Kanwal Farooqi
Amee Shah
Noa Zemer-Wassercug
Harsimran Singh
Brett Anderson
Emile Bacha
David Kalfa
Affiliated Authors:
David Blitzer
Ismail Bouhout
Eliana Al Haddad
Matthew Lewis
Kanwal Farooqi
Amee Shah
Noa Zemer-Wassercug
Brett Anderson
Emile Bacha
David Kalfa
Columbia Affiliation:
Author Keywords:
congenital
tricuspid valve
ecmo, extracorporeal membrane oxygenation
mr, mitral regurgitation
rvoto, right ventricular outflow tract obstruction
sv, single ventricle
tr, tricuspid valve regurgitation
ts, tricuspid stenosis
tv, tricuspid valve
cctga, congenitally corrected transposition of the great arteries
elink
Publication Type:
Article
Unique ID:
10.1016/j.xjon.2022.06.017
PMID:
36172453
DOI:
10.1016/j.xjon.2022.06.017
Journal:
JTCVS Open
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: